T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease.
Shadyab AH, LaCroix AZ, Matthews G, Bennett D, Shadyab AA, Tan D, Thomas RG, Mason J, Lopez A, Askew B, Donahue L, Kaplita S, Qureshi IA, Huisa B, Feldman HH; Alzheimer's Disease Cooperative Study T2 Protect AD Study Group.
Shadyab AH, et al. Among authors: qureshi ia.
Alzheimers Dement (N Y). 2022 Mar 14;8(1):e12265. doi: 10.1002/trc2.12265. eCollection 2022.
Alzheimers Dement (N Y). 2022.
PMID: 35310528
Free PMC article.